Paul Rutgeerts

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis

Kathleen Machiels, Marie Joossens, João Sabino et al. · Gut · 2013 · 1.8K citations

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

Marie Joossens, Geert Huys, Margo Cnockaert et al. · Gut · 2011 · 1K citations

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 883 citations

Gastroenterology, Tight Control Management, Clinical Gastroenterology +3

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease

G. Van Assche, Dirk Vanbeckevoort, Didier Bielen et al. · The American Journal of Gastroenterology · 2003 · 378 citations